These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 8326078

  • 1. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB, Lavori PW, Goldenberg IM, Baker LA, Pollack MH, Sachs GS, Rosenbaum JF, Deltito JA, Leon A, Shear K.
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [Abstract] [Full Text] [Related]

  • 2. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo.
    Pollack MH, Otto MW, Sachs GS, Leon A, Shear MK, Deltito JA, Keller MB, Rosenbaum JF.
    J Affect Disord; 1994 Apr; 30(4):273-81. PubMed ID: 8014326
    [Abstract] [Full Text] [Related]

  • 3. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 Apr; 365():39-45. PubMed ID: 1862733
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S, Rosenberg NK, Kullingsjö H, Ottosson JO, Bech P, Bruun-Hansen J, Hanson L, Lorentzen K, Mellergård M, Rasmussen S.
    Acta Psychiatr Scand Suppl; 1991 Apr; 365():18-27. PubMed ID: 1862730
    [Abstract] [Full Text] [Related]

  • 5. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
    Sheikh JI, Swales PJ.
    Int J Psychiatry Med; 1999 Apr; 29(1):107-17. PubMed ID: 10376237
    [Abstract] [Full Text] [Related]

  • 6. Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.
    Br J Psychiatry; 1992 Feb; 160():191-202; discussion 202-5. PubMed ID: 1540759
    [Abstract] [Full Text] [Related]

  • 7. Pattern of placebo response in panic disorder.
    Shear MK, Leon AC, Pollack MH, Rosenbaum JF, Keller MB.
    Psychopharmacol Bull; 1995 Feb; 31(2):273-8. PubMed ID: 7491379
    [Abstract] [Full Text] [Related]

  • 8. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W, Roth SM, Argyle N, Buller R, Lavori P, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 Feb; 241(3):151-8. PubMed ID: 1790160
    [Abstract] [Full Text] [Related]

  • 9. A comparison of symptom determinants of patient and clinician global ratings in patients with panic disorder and depression.
    Leon AC, Shear MK, Klerman GL, Portera L, Rosenbaum JF, Goldenberg I.
    J Clin Psychopharmacol; 1993 Oct; 13(5):327-31. PubMed ID: 8227491
    [Abstract] [Full Text] [Related]

  • 10. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 11. Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo.
    Cassano GB, Toni C, Petracca A, Deltito J, Benkert O, Curtis G, Hippius H, Maier W, Shera D, Klerman G.
    Eur Neuropsychopharmacol; 1994 Mar; 4(1):47-53. PubMed ID: 8204996
    [Abstract] [Full Text] [Related]

  • 12. Panic disorder: long-term pharmacotherapy and discontinuation.
    Rickels K, Schweizer E.
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 14. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
    Schweizer E, Rickels K, Weiss S, Zavodnick S.
    Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
    [Abstract] [Full Text] [Related]

  • 15. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly.
    Weissman MM, Prusoff B, Sholomskas AJ, Greenwald S.
    J Clin Psychopharmacol; 1992 Jun; 12(3):175-82. PubMed ID: 1629383
    [Abstract] [Full Text] [Related]

  • 16. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
    Rickels K, Chung HR, Csanalosi IB, Hurowitz AM, London J, Wiseman K, Kaplan M, Amsterdam JD.
    Arch Gen Psychiatry; 1987 Oct; 44(10):862-6. PubMed ID: 3310952
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia].
    León CA, De Arango MV, Arevalo W, Calvo A, Montoya A, León A.
    Acta Psiquiatr Psicol Am Lat; 1990 Oct; 36(1-2):59-72. PubMed ID: 2073024
    [Abstract] [Full Text] [Related]

  • 18. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.
    Woods SW, Nagy LM, Koleszar AS, Krystal JH, Heninger GR, Charney DS.
    J Clin Psychopharmacol; 1992 Feb; 12(1):32-8. PubMed ID: 1552038
    [Abstract] [Full Text] [Related]

  • 19. Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response.
    Rosenberg R, Bech P, Mellergård M, Ottosson JO.
    Acta Psychiatr Scand Suppl; 1991 Feb; 365():46-52. PubMed ID: 1862734
    [Abstract] [Full Text] [Related]

  • 20. Predictors of response to alprazolam and placebo in patients with panic disorder.
    Woodman CL, Noyes R, Ballenger JC, Lydiard RB, Sievers G, Mihalko D.
    J Affect Disord; 1994 Jan; 30(1):5-13. PubMed ID: 8151049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.